Similar companies
Related EMIS Industry Reports
Remegen Co., Ltd. is mainly engaged in the discovery, research and development, production and commercialization of innovative biological drugs, mainly covering major diseases such as autoimmune diseases, tumors and ophthalmology. The company's main products include antibody drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and double antibodies and other therapeutic antibody drugs. The company was established in 2008 and is headquartered in Yantai Free Trade Pilot Zone, Shandong Province.
Headquarters
No. 58, Beijing Middle Road, Yantai Development Zone, Yantai Area, China (Shandong) Pilot Free Trade Zone, Shandong Province
Yantai; Shandong;
Postal Code: 264006
Contact Details: Purchase the Remegen Co., Ltd. report to view the information.
Website: http://www.remegen.cn
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service